DOI: 10.1128/IAI.00592-18
Article Information
PubMed
Published By
History
- Received July 27, 2018
- Returned for modification August 7, 2018
- Accepted October 9, 2018
- Published online December 19, 2018.
Copyright & Usage
Copyright © 2018 Micheva-Viteva et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Editors and / or Reviewers
- Manuela Raffatellu, Editor, University of California San Diego School of Medicine
Article Versions
- Accepted Manuscript version (October 15, 2018).
- You are viewing the most recent version of this article.
Author Information
- Sofiya N. Micheva-Vitevaa,
- Brittany N. Rossb,
- Jun Gaoa,
- Samantha Adikaria,
- Pengfei Zhangc,
- Judith R. Mouranta,
- Terry H. Wud,
- James H. Wernerc,
- Alfredo G. Torresb and
- Elizabeth Hong-Gellera
- aBioscience Division, Los Alamos National Laboratory, Los Alamos, New Mexico, USA
- bDepartment of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA
- cCenter for Integrated Nanotechnologies, Los Alamos National Laboratory, Los Alamos, New Mexico, USA
- dUniversity of New Mexico Health Sciences Center, Department of Internal Medicine, Albuquerque, New Mexico, USA
- Address correspondence to Elizabeth Hong-Geller, ehong{at}lanl.gov.
Citation Micheva-Viteva SN, Ross BN, Gao J, Adikari S, Zhang P, Mourant JR, Wu TH, Werner JH, Torres AG, Hong-Geller E. 2019. Increased mortality in mice following immunoprophylaxis therapy with high dosage of nicotinamide in Burkholderia persistent infections. Infect Immun 87:e00592-18. https://doi.org/10.1128/IAI.00592-18.
